Enhancing Primary Health Care Services: Strategies and Insights

By Melike Belenli Gümüş

November 27, 2024

Enhancing primary health care services is crucial for improving health outcomes and system efficiency. A recent article from Iran explores strategies to strengthen primary health care (PHC) systems, focusing on interventions from various countries.

The Importance of Primary Health Care

Primary health care serves as the foundation of a robust healthcare system. It offers comprehensive services, including prevention, treatment, and rehabilitation. Effective PHC can lead to universal health coverage, a goal emphasised by the World Health Organization. By focusing on prevention and health promotion, PHC addresses the root causes of health issues, making it an efficient approach. In Iran, despite the successful implementation of PHC, evolving health needs present challenges that require innovative solutions.

Strategies for Improvement

Countries like Qatar, Oman, and Türkiye have implemented various strategies to enhance their PHC systems. Qatar’s Primary Health Care Corporation operates 27 health centres, providing services such as dental care, radiology, and physiotherapy. The introduction of the Ehteraz® contact tracing application and remote healthcare access channels exemplifies Qatar’s innovative approach. In Oman, the focus has been on building a capable PHC workforce. The density of physicians increased from 7.16 per 10,000 people in 2005 to 21.7 in 2015. Turkey’s Health Transformation Program has doubled the healthcare workforce, improving access to public facilities through reforms like the family medicine model.

Challenges and Solutions

Despite progress, challenges remain in implementing PHC reforms. Stakeholders in countries like Türkiye have highlighted issues such as resource allocation and infrastructure. Solutions include adopting electronic health services and enhancing community participation. These measures can improve service delivery and patient satisfaction. In Georgia, retraining programs for general practitioners and nurses aim to bridge the skills gap caused by historical challenges.

Future Directions

The future of PHC lies in continuous improvement and adaptation. Policymakers must focus on preventive care, reducing mortality rates, and increasing life expectancy. Focusing on health education and screening programs will be vital. As countries strive for universal health coverage, PHC systems must evolve to meet changing needs. The integration of technology and community involvement will play a significant role in this evolution.

Conclusion

Enhancing primary health care services is essential for achieving better health outcomes. By adopting innovative strategies and addressing challenges, countries can improve their PHC systems. This will lead to more efficient healthcare delivery and improved patient satisfaction. As we look to the future, the commitment to strengthening PHC will be crucial in achieving universal health coverage and improving global health standards.

Reference url

Recent Posts

Datroway Metastatic Breast Cancer: FDA Grants Priority Review for Breakthrough Treatment

By HEOR Staff Writer

February 4, 2026

Datroway metastatic breast cancer treatment has gained Priority Review from the US Food and Drug Administration (FDA) for first-line use in adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) ineligible for PD-1/PD-L1 inhibitors. This milestone for AstraZeneca and ...
Ozempic Public Funding Approval in Portugal: Key Insights and Implications

By HEOR Staff Writer

February 3, 2026

Ozempic public funding is now approved in Portugal for specific adults with type 2 diabetes. Infarmed's recent decision reimburses semaglutide (Ozempic) through the National Health Service (SNS). It targets those with inadequately controlled type 2 diabetes, BMI ≥30 kg/m², or high cardiovascular ...
FDA Confirms GLP-1 RA Safety Review: No Increased Suicidal Risk

By HEOR Staff Writer

February 2, 2026

GLP-1 RA Safety Review Clears Suicidal Risk Concerns In a pivotal GLP-1 RA safety review, the U.S. Food and Drug Administration (FDA) has concluded, following an extensive analysis of clinical and real-world data, that glucagon-l...